Pharmacy
The leaders of the Senate Special Committee on Aging Wednesday targeted the Daraprim spike hike by Turing Pharmaceutical founder Martin Shkreli during the first of a series of hearings investigating abrupt and dramatic price increases in prescription drugs that are no longer protected by patents.
Technology and connectivity will continue its steady infiltration of the healthcare landscape, branding and trust take priority over convenience, and the advancement and integration of connected health technologies will hinge on cybersecurity in 2016, PwC said.
The growth of specialty drugs, and the pressures pharma mergers place on supply chain operations are just a few trends experts at McKesson Pharmacy Optimization expect to shape hospital pharmacy operations in 2016, according to a new report.
Pharmaceutical company Novartis will pay $370 million to settle claims that it gave kickbacks to specialty pharmacies in exchange for recommending two of its drugs, the U.S. Justice Department Southern District of New York announced this week.
Pharmaceutical giant Pfizer on Sunday said it would merge with Botox maker Allergan in a $160 billion deal that would shift the company's executive offices to Ireland in a tax-saving "inversion" deal that is sure to come under heavy regulatory scrutiny.
The U.S. Food and Drug Administration on Wednesday approved the first nasal spray version of naloxone hydrochloride, better known as Narcan, in hopes that the ease of delivery will help combat the opioid epidemic.
People with hepatitis C who sought prescriptions for highly effective but pricey new drugs were significantly more likely to get turned down if they had Medicaid coverage than if they were insured by Medicare or private commercial policies, a recent study found.
Cancer patients shopping on federal and state insurance marketplaces often find it difficult to determine whether their drugs are covered and how much they will pay for them, the advocacy arm of the American Cancer Society says in a report that also calls on regulators to restrict how much insurers can charge patients for medications.
The retail health clinic wave shows no sign of crashing, according to a new report by Accenture, with experts saying the number of these outposts will likely hit 3,000 by 2017.
In 31 states and the District of Columbia, silver-level plans cover fewer than seven of the 10 most common drug treatment options or charge consumers more than $200 a month in cost sharing, according to an analysis of 2015 silver plans by consultant group Avalere Health.